DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Apidra (Insulin Glulisine) - Current Clinical Trials

 
 



Apidra Related Clinical Trials

Comparison of Apidra to Regular Insulin in Hospitalized Patients [Completed]

Insulin Glargine "All to Target" Trial [Completed]

Treatment Satisfaction of Insulin Glargine Plus Insulin Apidra Compared With NPH Insulin Plus Insulin Apidra in Recently Diagnosed Type 1 Diabetes Children and Adolescents [Terminated]

Expanded PK and PD of Insulin Glulisine Versus Insulin Aspart in Healthy Volunteers [Completed]

The Effect of Insulin Glulisine Compared With Insulin Aspart on Breakfast Post Prandial Glucose Levels in Prepubertal Children [Completed]

Better Acceptance of Single Injection Apidra Added to Once Daily Lantus Versus Twice Daily Premixed Insulin in Real Life Use Setting [Terminated]

Comparator Trial Using Insulin Glulisine vs. Insulin Lispro for Treatment of Gestational Diabetes [Active, not recruiting]

Pharmacodynamic and Pharmacokinetic Effects of Insulin Glulisine in Obese Subjects With Type 2 Diabetes After a Standard Meal in Comparison to Insulin Aspart [Completed]

Efficacy and Safety of Lixisenatide Versus Insulin Glulisine on Top of Insulin Glargine With or Without Metformin in Type 2 Diabetic Patients [Completed]

Insulin Glulisine Administered Pre-meal Versus Post-meal in Adult Subjects With Type 2 Diabetes Mellitus Receiving Insulin Glargine as Basal Insulin [Completed]

Test of the Efficacy and Safety of Insulin Glulisine Injected Subcutaneously in Patients With Type 1 Diabetes Mellitus [Completed]

Apidra Children & Adolescents Study [Completed]

Effect of Insulin Glulisine vs Regular Human Insulin on Postprandial Endothelial Function in Type 2 Diabetes [Completed]

Effect of Lantus and Apidra in Patients With Acute ST Elevation Myocardial Infarction [Terminated]

Intensive Insulin Glulisine Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Basal Insulin and Oral Glucose-lowering Drugs [Completed]

Safety and Effectiveness Study of Intranasal Insulin Glulisine on Cognitive and Memory in Mild-Mod AD Patients. [Completed]

Insulin Glargine Plus Insulin Glulisine Multiple Daily Injections (MDI) Versus Premix Insulin Treatment in Subjects With Diabetes Mellitus (Type 1 or Type 2) [Completed]

baSal BoluS Therapy in patIenTs With TypE 1 Diabetes Mellitus [Completed]

Insulin Glulisine and Aspart in Postprandial Glycemic Control After High-GI Meal in Children With Type 1 Diabetes Mellitus [Completed]

Effect of LIXIsenatide on the Renal System [Recruiting]

Gulf, Lantus, Apidra Evaluation in Type 1 Diabetics Study [Completed]

Insulin Exposure and Glucose Response to Meals in Type 1 Diabetic Subjects Administered Two Different Insulin Regimens Compared to the Endogenous Insulin Exposure and Glucose Response to Meals In Healthy Adult Controls [Completed]

Variable Bolus Regimen 1-2-3 for Type 2 Diabetes Mellitus [Completed]

Study of Safety and Effectiveness of Apidra® in Combination With Basal Insulin in Patients With Type 1 & 2 Diabetes Mellitus [Completed]

Comparison of Insulin Glargine/Insulin Glulisine Regimen to Insulin Aspart/Insulin Aspart Protamine 30/70 in Type 2 Diabetes Mellitus Patients (T2DM) [Completed]

Insulin Glulisine in Diabetes Mellitus, Type 2 [Completed]

Comparison of a Basal Plus One Insulin Regimen With a Biphasic Insulin Regimen in Type 2 Diabetes Patients [Completed]

Self Titration With Apidra to Reach Target Study (START) [Completed]

Effect of Insulin Glulisine Compared to Insulin Aspart and Insulin Lispro When Administered by Continuous Subcutaneous Insulin Infusion (CSII) on Specific Pump Parameters in Patient With Type 1 Diabetes Mellitus [Completed]

Insulin Glulisine, Insulin Lispro and Insulin Glargine in Type 1 or 2 Diabetes Mellitus [Completed]

Insulin Glulisine, Diabetes Mellitus Type 1 [Completed]

Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease [Not yet recruiting]

Establishing Cardiovascular Biomarkers to Define Preferred Lantus® Use [Recruiting]

Human Insulin Analogs: Evaluation of Inflammatory mRNA Expression of Macrophages and Endothelial Function of Short-acting Insulin - HERMES Pilot Study [Active, not recruiting]

Basal/Bolus Versus Sliding Scale Insulin In Hospitalized Patients With Type 2 Diabetes [Completed]

Insulin Glulisine in Type 1 Diabetes Mellitus [Completed]

OPAL - Insulin Glulisine, Diabetes Mellitus [Completed]

Insulin Glulisine in Adult Subjects With Type 2 Diabetes Receiving Insulin Glargine as Basal Insulin [Completed]

Efficacy and Safety of Insulin Glulisine in Type 1 Diabetes Mellitus [Completed]

Normal Versus Dual Wave Insulin Bolus for High-protein Food [Not yet recruiting]

Basal Bolus Insulin Versus SSRI in Type 2 Diabetes Undergoing General Surgery [Completed]

Insulin Glulisine in Type 2 Diabetic Patients [Completed]

Dose-Exposure-Response in Type 1 Diabetes Mellitus [Completed]

CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Participants With Type 1 Diabetes Mellitus (T1DM) [Active, not recruiting]

Insulin Therapy in Chronic Obstructive Pulmonary Disease (COPD) Exacerbations [Terminated]

A Pharmacokinetic and Glucodynamic Study of Subcutaneously Administered Insulin Analogs With rHuPH20 Compared to Insulin Analogs Alone [Completed]

Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Patients With Type 2 Diabetes Mellitus [Completed]

Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes Mellitus [Completed]

Trial Between a Computer-Guided Insulin Infusion Protocol Versus a Standard Insulin Infusion Algorithm in Medical ICU [Completed]

Investigation of the Safety of Intranasal Glulisine in Down Syndrome [Recruiting]

Comparison of the Ability of Glulisine With Lispro to Control Type 1 Diabetes Mellitus in Children and Adolescents [Completed]

REsearching Coronary REduction by Appropriately Targeting Euglycemia (RECREATE Pilot Study) [Completed]

Efficacy and Safety of Insulin Glulisine in Type 2 Diabetes Mellitus [Completed]

Efficacy Study on the Control of Blood Glucose Concentration in Type 1 Diabetic Patients [Completed]

Treatment With Continuous Sub-cutaneous Insulin Infusion Via a Portable Pump Versus Discontinuous Insulin Infusion Via Multiple-injections in Type 2 Diabetes [Recruiting]

Basal Bolus Versus Basal Insulin in Type 2 Diabetes Mellitus (DM) [Completed]

Opposing Step-by-step Insulin Reinforcement to Intensified Strategy [Completed]

Glulisine Pre- and Postmeal [Completed]

A Study to Characterize Regimens of Basal Insulin Intensified With Either Symlin® or Rapid Acting Insulin in Patients With Type 2 Diabetes [Completed]

Insulin Glargine for Diabetes Metabolism(DM)Type II Patients Under Enteral Nutrition [Terminated]

Basal-bolus and Premixed Insulin Regimens in Hospitalized Patients With Type 2 Diabetes (PININ Study) [Terminated]

Basal Insulin in the Management of Patients With Diabetic Ketoacidosis (DKA) [Completed]

Insulin Glargine Injection Treatment in Place of Thiazolidinedione (TZD), Sulfonylurea, or Metformin in Triple Agent Therapy for Type 2 Diabetes Mellitus (T2DM) Adult Subjects With Unsatisfactory Control [Terminated]

Evaluation of the Prandial Treatment Adjustment Effect Via Continuous Glucose Monitoring on Type 2 Diabetes Mellitus (DM) Patients Uncontrolled With a Basal Insulin or Premix Once a Day [Completed]

Insulin Administration Plus a Telemedicine System (Diabetes Interactive Diary - DID) vs Insulin Plus Common Practice [Recruiting]

ELEONOR STUDY: Insulin Glulisine in Type 2 Diabetes Mellitus. [Completed]

Evaluation of the Safety and Efficacy of Insulin Glargine + Glulisine or Insulin Regular + NPH Insulin (Isophane Insulin) Use in Type 2 Diabetes Mellitus Patients With Moderate Renal Failure. [Completed]

Insulins Glargine and gluLisine strAtegy Versus Premixed Insulin strAteGy: a cOmparative Study [Completed]

Glargine Dosing in Hospitalized Patients With Type 2 Diabetes and Renal Insufficiency [Recruiting]

Diabetes in the Elderly: Prospective Study [Completed]

Glulisine + Lantus in Type I Patients [Completed]

Glulisine + Lantus in Type I Patients [Completed]

Various Insulin Regimens for Diabetic Inpatients With Cirrhosis Trial [Not yet recruiting]

INSPIRE Diabetes Study: Basal Bolus Insulin as Primary Treatment of Type 2 Diabetes [Completed]

TReatment by Insulin Continuous Infusion in Type 2 DIAbetes [Recruiting]

12 Week,Comparing Safety of HMR1964 & Insulin Aspart Used in Continuous Subcutaneous Infusion in Type 1 Diabetes. [Completed]

Basal Bolus vs. Sliding Scale for Treatment of Diabetic Patients in Medical Wards [Not yet recruiting]

Dapagliflozin As Additional Treatment To Liraglutide And Insulin In Patients With Type 1 Diabetes [Recruiting]

Combined Diabetes-Renal Multifactorial Intervention In Patients With Advanced Diabetic Nephropathy (ADN) [Completed]

The Differential Effects of Diabetes Therapy on Inflammation [Recruiting]

Selecting Insulin Analogs for Closed-Loop Control Using Multiplex Pharmacokinetic Profiling [Active, not recruiting]

Comparative Trial Between 3 Types of Insulin Infusion Protocols [Completed]

Closed-loop Control of Postprandial Glucose Levels in Children and Adults With Type 1 Diabetes [Not yet recruiting]

Closed-loop Control of Glucose Levels (Artificial Pancreas) for 5 Days in Adults With Type 1 Diabetes [Not yet recruiting]

Intensive Glycemic Control on Infectious Morbidity In Patients With Acute Leukemia [Withdrawn]

Efficacy and Safety of a Glargine-based Hospital Discharge Algorithm in Coronary Artery Bypass Graft(CABG) Patients [Active, not recruiting]

Basal Bolus Versus Human Insulin in Hospitalized Patients With Diabetes in Paraguay [Completed]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017